Management and control of type 2 diabetes mellitus in Lebanon:Results from the International Diabetes Management Practices Study Wave 6

作     者：Hala Ahmadieh Marie-Therese Sawaya Sami T Azar 

作者机构：Department of Medicine Beirut Arab University Medical Affairs Department Sanofi-aventis Lebanon Department of Internal Medicine Division of Endocrinology American University of Beirut-Medical Center 

出 版 物：《World Journal of Diabetes》 (世界糖尿病杂志（英文版）（电子版）)

年 卷 期：2019年第10卷第4期

页      面：249-259页

核心收录：

学科分类：10[医学] 

主　　题：Diabetes complications Dyslipidemia Hypertension Blood pressure control Glycemic control 

摘      要：BACKGROUND Diabetes mellitus is a worldwide public health problem associated with significant complications. There is lack of data on the quality of care of patients with diabetes, specifically among the non-Western countries. Efforts have been made in Lebanon to better study the characteristics of patients with diabetes mellitus in order to improve glycemic control and prevent late-term *** To investigate control and therapeutic management of patients with diabetes mellitus in the current medical practice in *** Wave 6 of the International Diabetes Management Practice Study in Lebanon is an international and multicenter study involving selected *** Only 1 patient with type 1 diabetes and 595 patients with type 2 diabetes were included in Wave 6. Average age was around 60 years, with a mean body mass index of 30. The mean fasting serum glucose was 159.42 mg/dL, and the mean glycosylated hemoglobin(HbA1 c) level was 7.98 with around 30% achieving an HbA1 c target of 7%. More patients were on oral anti-diabetic *** of diabetic complications has improved over the years. A large percentage is diagnosed with hypertension and dyslipidemia, the majority ofwhom were treated but only a small percentage were *** Diabetes, with its associated dyslipidemia and hypertension, is still not very well controlled. Screening for diabetes complications has improved over the *** need to have more proper care, and physicians need to follow diabetes guidelines, and to have a larger number of patients who have appropriate treatment of diabetes, hypertension and lipids.